We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Screening FDA-approved oncology drugs identifies romidepsin as a viable therapeutic candidate for osteosarcoma, implying its potential effectiveness.
Toxicity and therapeutic indices on Small Airway Epithelial Cells
No takes yet. Share an insight, caveat, or question.
Seiden et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: